[EN] NOVEL HETEROARYL-CARBOXAMIDE DERIVATIVES AS PDK1 INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE HÉTÉROARYL-CARBOXAMIDE UTILISÉS COMME INHIBITEURS DE LA PDK1
申请人:SCHERING CORP
公开号:WO2012058176A1
公开(公告)日:2012-05-03
This invention relates to certain Heteroaryl Carboxamide derivatives of Formula (I) as inhibitors of 3-phosphoinositide-dependent protein kinase (PDK-1). The compounds can be useful in inhibiting the proliferation of cancer cells, and other aberrant conditions where the PDK-1 signaling pathway is overstimulated.